Published in Infect Immun on December 01, 1980
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Common themes in microbial pathogenicity. Microbiol Rev (1989) 7.78
Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect Immun (1996) 4.08
Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc Natl Acad Sci U S A (1988) 3.83
The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest (2003) 3.46
Adherence of group A streptococci to fibronectin on oral epithelial cells. Infect Immun (1983) 3.11
Role of pili in the adherence of Pseudomonas aeruginosa to injured tracheal epithelium. Infect Immun (1984) 2.92
Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin Microbiol Rev (1991) 2.87
Evidence for mucins and sialic acid as receptors for Pseudomonas aeruginosa in the lower respiratory tract. Infect Immun (1983) 2.86
Adherence of mucoid and nonmucoid Pseudomonas aeruginosa to acid-injured tracheal epithelium. Infect Immun (1983) 2.75
Role of pili in adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells. Infect Immun (1988) 2.63
Adherence of streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells. Infect Immun (1983) 2.48
Quantitation of adherence of mucoid and nonmucoid Pseudomonas aeruginosa to hamster tracheal epithelium. Infect Immun (1985) 2.17
Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes. Infect Immun (1982) 1.99
Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect Immun (1991) 1.93
Siderophore-mediated iron acquisition from transferrin by Pseudomonas aeruginosa. Infect Immun (1986) 1.71
Serial isolates of Pseudomonas aeruginosa from a cystic fibrosis patient have identical pilin sequences. Infect Immun (1988) 1.68
Flagellar preparations from Pseudomonas aeruginosa: isolation and characterization. Infect Immun (1982) 1.67
Characterization of the Pseudomonas aeruginosa pilus adhesin: confirmation that the pilin structural protein subunit contains a human epithelial cell-binding domain. Infect Immun (1989) 1.58
Production of the Pseudomonas aeruginosa neuraminidase is increased under hyperosmolar conditions and is regulated by genes involved in alginate expression. J Clin Invest (1992) 1.58
Glycosphingolipid receptors for Pseudomonas aeruginosa. Infect Immun (1990) 1.57
Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis. J Clin Microbiol (1990) 1.44
Characterization of the binding of Pseudomonas aeruginosa alginate to human epithelial cells. Infect Immun (1987) 1.37
Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects. Infect Immun (1992) 1.30
Chemical and biological activities of a 64-kilodalton outer sheath protein from Treponema denticola strains. J Bacteriol (1991) 1.29
Interaction of viral envelope glycoproteins with fibronectin. Infect Immun (1983) 1.21
Role of pili in the adherence of Pseudomonas aeruginosa to mouse epidermal cells. Infect Immun (1987) 1.13
Interaction of a rat lung lectin with the exopolysaccharides of Pseudomonas aeruginosa. Infect Immun (1983) 1.10
Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: role of neutrophils and leukotriene B4. Infect Immun (1993) 1.04
Role of sialic acid in saliva-mediated aggregation of Pseudomonas aeruginosa isolated from cystic fibrosis patients. Infect Immun (1987) 0.99
Presence of bacterial glycocalyx and fimbriae on Pasteurella haemolytica in feedlot cattle with pneumonic pasteurellosis. Can J Vet Res (1989) 0.97
Antigen-antibody interactions: elucidation of the epitope and strain-specificity of a monoclonal antibody directed against the pilin protein adherence binding domain of Pseudomonas aeruginosa strain K. Protein Sci (1992) 0.95
Ability of oral bacteria to degrade fibronectin. Infect Immun (1986) 0.95
Bacterial reservoirs in cystic fibrosis. Arch Dis Child (1990) 0.94
In vivo-induced genes in Pseudomonas aeruginosa. Infect Immun (2000) 0.92
Antibody response to Pseudomonas aeruginosa exoproducts in cancer patients. J Clin Microbiol (1982) 0.92
A possible role for lysozyme in determining acute exacerbation in chronic bronchitis. Clin Exp Immunol (1995) 0.88
Virulence determinants in Pseudomonas aeruginosa strains from urinary tract infections. Epidemiol Infect (1992) 0.87
Effects of fibronectin and other salivary macromolecules on the adherence of Escherichia coli to buccal epithelial cells. Infect Immun (1987) 0.87
Pathogenesis and management of lung disease in cystic fibrosis. J R Soc Med (1991) 0.85
Characterization of antibody-mediated inhibition of Pseudomonas aeruginosa adhesion to epithelial cells. Infect Immun (1992) 0.84
Nosocomial pneumonia in patients in intensive care units. West J Med (1985) 0.75
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun (1978) 32.33
Bacterial adherence in oral microbial ecology. Annu Rev Microbiol (1975) 11.44
Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child (1958) 9.70
Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet (1976) 7.15
Cystic fibrosis. Am Rev Respir Dis (1976) 6.62
Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect Immun (1980) 6.19
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med (1973) 5.53
Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med (1969) 5.28
Adherence of Neisseria gonorrhoeae to urethral mucosal cells: an electron-microscopic study of human gonorrhea. J Infect Dis (1972) 4.51
[Research on O-antigens of Pseudomonas aeruginosa]. Z Hyg Infektionskr (1957) 4.11
Proportional distribution and relative adherence of Streptococcus miteor (mitis) on various surfaces in the human oral cavity. Infect Immun (1972) 3.70
Studies of introital colonization in women with recurrent urinary infections. VII. The role of bacterial adherence. J Urol (1977) 3.20
Parameters affecting the association of vibrios with the intestinal surface in experimental cholera. Infect Immun (1972) 3.10
Incidence of mucoid Pseudomonas aeruginosa from clinical sources. Appl Microbiol (1969) 3.04
Adherence of enteropathogenic Escherichia coli to intestinal epithelium in vivo. Infect Immun (1975) 2.91
Association of respiratory tract colonization with adherence of gram-negative bacilli to epithelial cells. J Infect Dis (1979) 2.70
Research in cystic fibrosis (third of three parts). N Engl J Med (1976) 2.29
Selective adherence as a determinant of the host tropisms of certain indigenous and pathogenic bacteria. Infect Immun (1976) 1.87
Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.86
Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas. J Clin Microbiol (1975) 1.81
Pseudomonas: the compromised host. Hosp Pract (1976) 1.75
Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis. Acta Pathol Microbiol Scand Suppl (1975) 1.53
Upper respiratory tract carriage of gram-negative enteric bacilli by hospital personnel. JAMA (1970) 1.34
Load-bearing capacity of functioning alumina dental endosseous implants. J Dent Res (1976) 0.92
Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells. Infect Immun (1980) 6.19
Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int J Syst Bacteriol (1998) 5.34
Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med (1969) 5.28
Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother (1999) 4.29
A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis (1979) 4.27
Isolation of cDNA clones for the human complement protein factor B, a class III major histocompatibility complex gene product. Proc Natl Acad Sci U S A (1982) 3.89
Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa. J Infect Dis (1987) 3.79
Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J Bacteriol (1997) 3.60
Intracellular survival of Burkholderia pseudomallei. Infect Immun (1996) 3.56
Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells. J Infect Dis (1981) 3.51
Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med (1972) 3.49
Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. J Infect Dis (1988) 3.01
Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med (1970) 2.94
Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun (2001) 2.76
Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun (1982) 2.76
Effect of rpoS mutation on the stress response and expression of virulence factors in Pseudomonas aeruginosa. J Bacteriol (1999) 2.72
Association of respiratory tract colonization with adherence of gram-negative bacilli to epithelial cells. J Infect Dis (1979) 2.70
Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol Infect (1997) 2.69
Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature (1984) 2.69
Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay. J Infect Dis (1978) 2.60
Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog (2001) 2.52
The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol Microbiol (1998) 2.46
Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med (1983) 2.28
Molecular map of the murine S region. Proc Natl Acad Sci U S A (1983) 2.24
Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis. J Clin Microbiol (1984) 2.23
Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun (1978) 2.15
Time-limited certification and recertification: the program of the American Board of Internal Medicine. The Task Force on Recertification. Ann Intern Med (1991) 1.83
Use of a cDNA clone for the fourth component of human complement (C4) for analysis of a genetic deficiency of C4 in guinea pig. Proc Natl Acad Sci U S A (1983) 1.82
Demonstration of an iron-siderophore-binding protein in the outer membrane of Pseudomonas aeruginosa. Infect Immun (1983) 1.82
Toxins of Pseudomonas aeruginosa: new perspectives. Rev Infect Dis (1983) 1.77
Isolation and characterization of Pseudomonas pseudomallei flagellin proteins. Infect Immun (1994) 1.77
Broad-host-range cloning and cassette vectors based on the R388 trimethoprim resistance gene. Biotechniques (1996) 1.70
Role of ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding L-ornithine N(5)-oxygenase. Infect Immun (1999) 1.70
Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect Immun (1989) 1.70
Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect Immun (1996) 1.70
Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations. Antimicrob Agents Chemother (1989) 1.69
Colonization in patients receiving and not receiving topical antimicrobial prophylaxis. Am J Respir Crit Care Med (1994) 1.68
Correlation between the prevalence of certain fungi and sick building syndrome. Occup Environ Med (1998) 1.68
Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Clin Microbiol (1986) 1.60
Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae. Infect Immun (1982) 1.59
Extracellular neuraminidase production by group B streptococci. Infect Immun (1977) 1.53
Clostridium sordellii infection and toxin neutralization. Pediatr Infect Dis J (1990) 1.53
Ribotype analysis of Pseudomonas pseudomallei isolates. J Clin Microbiol (1993) 1.52
Complete primary structure for the zymogen of human complement factor B. J Biol Chem (1984) 1.48
Growth and amino acid requirements of various strains of group B streptococci. J Clin Microbiol (1978) 1.47
Immunization against Pseudomonas aeruginosa. I. Induction of protection by an alcohol-precipitated fraction from the slime layer. J Infect Dis (1967) 1.47
Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence. Can J Microbiol (1985) 1.44
Pneumoconiosis among the activated-carbon workers. Arch Environ Health (1975) 1.43
Factors influencing release of type III antigens by group B streptococci. Infect Immun (1981) 1.41
Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest (1981) 1.40
The radiographic resolution of Streptococcus pneumoniae pneumonia. N Engl J Med (1975) 1.39
Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Dis (1994) 1.38
Aeration selects for mucoid phenotype of Pseudomonas aeruginosa. J Clin Microbiol (1986) 1.38
Pathogenesis of and immunity to melioidosis. Acta Trop (2000) 1.38
Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest (1981) 1.33
Pulmonary function in uncomplicated influenza. Am Rev Respir Dis (1969) 1.33
Pseudomonas aeruginosa exoenzyme S is an adhesion. Infect Immun (1991) 1.30
Molecular characterization of genetic loci required for secretion of exoproducts in Burkholderia pseudomallei. J Bacteriol (1999) 1.29
Fluid balance and the adult respiratory distress syndrome. Am Rev Respir Dis (1987) 1.28
Response to chemotherapy of pulmonary infection due to Mycobacterium kansasii. Am Rev Respir Dis (1975) 1.28
Purification of Pseudomonas aeruginosa exoenzyme S. Infect Immun (1987) 1.28
Bacterial adherence to epithelial cells in bacillary colonization of the respiratory tract. Am Rev Respir Dis (1980) 1.28
Syrian hamster female protein: analysis of female protein primary structure and gene expression. Science (1985) 1.28
An extracellular zinc metalloprotease gene of Burkholderia cepacia. Microbiology (2003) 1.27
The significance of biliary pressure in cholangitis. Arch Surg (1969) 1.27
Production of an extracellular toxic complex by various strains of Klebsiella pneumoniae. Infect Immun (1987) 1.26
Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. Am Rev Respir Dis (1986) 1.26
Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol (1988) 1.25
Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. Antimicrob Agents Chemother (1999) 1.25
Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model. Infect Immun (1981) 1.24
Pseudomonas aeruginosa exoproducts as pulmonary virulence factors. Can J Microbiol (1983) 1.23
The relationship between the clinical and pathologic features of poststreptococcal glomerulonephritis. A study of the early natural history. Medicine (Baltimore) (1968) 1.23
Studies on the ability of alginate to act as a protective immunogen against infection with Pseudomonas aeruginosa in animals. J Infect Dis (1985) 1.23
Phylogenetic conservation of a class III major histocompatibility complex antigen, factor B. Isolation and nucleotide sequencing of mouse factor B cDNA clones. J Biol Chem (1983) 1.23
Detection of airborne Stachybotrys chartarum macrocyclic trichothecene mycotoxins on particulates smaller than conidia. Appl Environ Microbiol (2005) 1.22
Pulmonary disease due to Mycobacterium Kansasii. An analysis of some factors affecting prognosis. Am Rev Respir Dis (1969) 1.21
Determinants of lung bacterial clearance in normal mice. J Clin Invest (1976) 1.21
The use of repeat skin tests to eliminate the booster phenomenon in serial tuberculin testing. Am Rev Respir Dis (1981) 1.20
Importance of a lipopolysaccharide-containing extracellular toxic complex in infections produced by Klebsiella pneumoniae. Infect Immun (1985) 1.19
DNA polymorphism of the C4 genes. A new marker for analysis of the major histocompatibility complex. N Engl J Med (1984) 1.19
Mycobacterium simiae. Clinical features and follow-up of twenty-four patients. Am Rev Respir Dis (1983) 1.19
Effect of pyochelin on Pseudomonas cepacia respiratory infections. Microb Pathog (1988) 1.18
Extracellular antigens of serotype III group B streptococci. Infect Immun (1980) 1.16